Search results for: Value-Based Pricing
Filter search results
Can and Should Value Based Pricing Be Applied to Molecular Diagnostics?
1 April 2012
…http://www.futuremedicine.com/doi/abs/10.2217/pme.12.99 Please cite as: Garau, M., Towse, A., Garrison, L., Housman, L. and Ossa, D., 2013. Can and should value-based pricing be applied to molecular diagnostics? Personalized Medicine, 10(1), pp.61-72….
OHE Presentations at HTAi: Tokyo 2016
24 May 2016
…Adrian Towse In a lunch time Symposium, Adrian Towse presented on “Making Value-Based Pricing a Reality – the Case for Multi-Indication Pricing”. Making value-based pricing a reality – the case…
The US Inflation Reduction Act: What Do the Experts Think?
25 May 2023
…“value” was not right or sustainable (referencing this STATA article), and in any case: would we want value-based pricing when a drug has been on the market for 10 years…
How Important are the Differences Between the EQ-5D-5L and EQ-5D-3L Value Sets?
24 March 2017
…three value sets – that is, the MVH 3L values for all 243 states described by the 3L instrument, and the crosswalk and 5L value set values for all 3,125…
Pricing and Paying for Cures: Early Experience with HTA of Gene Therapy in the USA
28 February 2019
…values have to be integrated into value-based pricing. Three are particularly relevant to gene therapies: i) the severity of the condition; ii) lifetime burden of illness; and iii) first to…
OHE at HESG: Value-based Assessment in the UK; Developing the EQ-5D-5L
23 January 2014
OHE’s contributions focused on approaches to implementing UK value-based assessment and the details of creating an EQ-5D-5L value set for England. The Health Economists’ Study Group (HESG), based in the…
Pricing Variations Within and Across Countries: Gauging Efficiency
25 February 2014
…Danzon of the Wharton School at the University of Pennsylvania to examine value-based pricing for pharmaceuticals. The research explores which approaches to pricing can produce the greatest efficiency within and…
OHE at ISPOR Europe 2018
…Value Based Pricing Versus WHO Fair Pricing. Which Delivers Universal Health Coverage? The World Health Organisation (WHO) is arguing that value-based pricing alone is not a viable basis for the…
Indication-Based Pricing: Are We All Onboard?
12 May 2020
…Zamora, B., 2019. Indication-Based Pricing (IBP) Discussion Paper. OHE Briefing, London: Office of Health Economics. Available at: https://www.ohe.org/publications/indication-based-pricing-ibp-discussion-paper-should-drug-pricesdiffer-indication Cole, A., Towse, A., Lorgelly, P. and Sullivan, R. (2018). Economics of…